Variant report
Variant | nsv525181 |
---|---|
Chromosome Location | chr2:49626781-49630633 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545047223 | chr2:49627408-49627409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551123879 | chr2:49627476-49627477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189223017 | chr2:49627477-49627478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140700481 | chr2:49627483-49627484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552024798 | chr2:49627491-49627492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs193110317 | chr2:49627523-49627524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533743950 | chr2:49627531-49627532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554932039 | chr2:49627554-49627555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182059021 | chr2:49627556-49627557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186742009 | chr2:49627575-49627576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555872706 | chr2:49627588-49627589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556282669 | chr2:49628803-49628804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148280530 | chr2:49628845-49628846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545155501 | chr2:49628859-49628860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554253926 | chr2:49628866-49628867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7579825 | chr2:49628870-49628871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188345351 | chr2:49628879-49628880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542815387 | chr2:49628884-49628885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs817039 | chr2:49628886-49628887 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs531872902 | chr2:49628898-49628899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141407314 | chr2:49628916-49628917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564712175 | chr2:49628933-49628934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555962992 | chr2:49628967-49628968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150815957 | chr2:49628969-49628970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565785125 | chr2:49628974-49628975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs817040 | chr2:49628993-49628994 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs554739825 | chr2:49629239-49629240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376088936 | chr2:49629250-49629251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561121202 | chr2:49629251-49629252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191547662 | chr2:49629281-49629282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565595988 | chr2:49629289-49629290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183500581 | chr2:49629306-49629307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35553986 | chr2:49629342-49629343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541033338 | chr2:49629367-49629368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138241283 | chr2:49629416-49629417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572403913 | chr2:49629422-49629423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs199919950 | chr2:49629473-49629474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs398080234 | chr2:49629482-49629483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs397735508 | chr2:49629483-49629484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186776910 | chr2:49629488-49629489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190789665 | chr2:49629495-49629496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142823568 | chr2:49629509-49629510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183341477 | chr2:49629516-49629517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538615177 | chr2:49629542-49629543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561354531 | chr2:49629545-49629546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536622610 | chr2:49629561-49629562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553739076 | chr2:49629562-49629563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146093750 | chr2:49629569-49629570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562177304 | chr2:49629584-49629585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536324174 | chr2:49629594-49629595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49627400-49627600 | Enhancers | Brain Germinal Matrix | brain |
2 | chr2:49628800-49629000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr2:49629200-49630800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr2:49630000-49631600 | Enhancers | Brain Germinal Matrix | brain |
5 | chr2:49630400-49631200 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr2:49630400-49631400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr2:49630400-49632400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr2:49630600-49632000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr2:49630600-49632200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr2:49630600-49632200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |